These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2964238)

  • 1. Activation of the carcinogen, 5-hydroxymethylchrysene, to the mutagenic sulphate ester by mouse skin sulphotransferase.
    Okuda H; Nojima H; Watanabe N; Miwa K; Watabe T
    Biochem Pharmacol; 1988 Mar; 37(5):970-3. PubMed ID: 2964238
    [No Abstract]   [Full Text] [Related]  

  • 2. A hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 5-hydroxymethylchrysene.
    Okuda H; Hiratsuka A; Nojima H; Watabe T
    Biochem Pharmacol; 1986 Feb; 35(3):535-8. PubMed ID: 3456226
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulphotransferase-mediated activation of the carcinogen 5-hydroxymethyl-chrysene. Species and sex differences in tissue distribution of the enzyme activity and a possible participation of hydroxysteroid sulphotransferases.
    Okuda H; Nojima H; Watanabe N; Watabe T
    Biochem Pharmacol; 1989 Sep; 38(18):3003-9. PubMed ID: 2783155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the carcinogen, 5-hydroxymethylchrysene, by glutathione conjugation via a sulphate ester in hepatic cytosol.
    Okuda H; Miwa K; Nojima H; Watabe T
    Biochem Pharmacol; 1986 Dec; 35(24):4573-6. PubMed ID: 3790172
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene.
    Amin S; Juchatz A; Furuya K; Hecht SS
    Carcinogenesis; 1981; 2(10):1027-32. PubMed ID: 7296756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.
    Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hymenolepis diminuta: lack of sulphate activation and sulphotransferase activity.
    Raines PS; Barrett J
    Exp Parasitol; 1988 Apr; 65(2):209-13. PubMed ID: 3162420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in drug conjugation and their consequences for drug toxicity. Sulfation, glucuronidation and glutathione conjugation.
    Mulder GJ
    Chem Biol Interact; 1986 Jan; 57(1):1-15. PubMed ID: 3081267
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of sulphate transfer from 4-nitrophenylsulphate to phenolic acceptors via liver cytosolic sulphotransferase.
    Anhalt E; Holloway CJ; Brunner G; Trautschold I
    Enzyme; 1982; 27(3):171-8. PubMed ID: 6951713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the decrease of tyrosine-O-sulphated proteins in Rous sarcoma-virus-transformed rat embryo fibroblasts, line 3Y1. Examination of the sulphate activation and tyrosyl-protein sulphotransferase systems.
    Liu MC; Suiko M; Lipmann F
    Biochem J; 1987 Oct; 247(1):201-6. PubMed ID: 2825656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes.
    Ogura K; Sohtome T; Sugiyama A; Okuda H; Hiratsuka A; Watabe T
    Mol Pharmacol; 1990 Jun; 37(6):848-54. PubMed ID: 2113604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 7-hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 7-hydroxymethylbenz[a]anthracene.
    Watabe T; Hakamata Y; Hiratsuka A; Ogura K
    Carcinogenesis; 1986 Feb; 7(2):207-14. PubMed ID: 3948310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic sulphation of bile salts in man.
    Lööf L; Wengle B
    Scand J Gastroenterol; 1979; 14(5):513-9. PubMed ID: 493853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolism and DNA binding of 6-nitro-5-methylchrysene and 5-methylchrysene.
    Shiue GH; el-Bayoumy K; Hecht SS
    Carcinogenesis; 1987 Sep; 8(9):1327-31. PubMed ID: 3621469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High stereoselectivity in mouse skin metabolic activation of methylchrysenes to tumorigenic dihydrodiols.
    Amin S; Huie K; Balanikas G; Hecht SS; Pataki J; Harvey RG
    Cancer Res; 1987 Jul; 47(14):3613-7. PubMed ID: 3594428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver.
    Miller EC; Miller JA; Boberg EW; Delclos KB; Lai CC; Fennell TR; Wiseman RW; Liem A
    Carcinog Compr Surv; 1985; 10():93-107. PubMed ID: 3904999
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene.
    Hecht SS; Rivenson A; Hoffmann D
    Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-initiating activity on mouse skin of bay region diol-epoxides of 5,6-dimethylchrysene and benzo[c]phenanthrene.
    Amin S; Desai D; Hecht SS
    Carcinogenesis; 1993 Oct; 14(10):2033-7. PubMed ID: 8222050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic metabolites of 5-methylchrysene.
    Pataki J; Lee H; Harvey RG
    Carcinogenesis; 1983; 4(4):399-402. PubMed ID: 6839413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide:DNA adducts in mouse skin.
    Melikian AA; LaVoie EJ; Hecht SS; Hoffmann D
    Cancer Res; 1982 Apr; 42(4):1239-42. PubMed ID: 7060000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.